Patents by Inventor Arnaud Gutierrez

Arnaud Gutierrez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210214713
    Abstract: Disclosed herein are a high-throughput continuous culture system and novel methodologies for the experimental evolution of natural and synthetic microbes using the continuous culture system. The microbial culture is exposed to a stress ramp function which is overlaid on top of a culture fitness function. The amount of stress applied to the culture is increased in response to increased fitness of the microbial culture.
    Type: Application
    Filed: February 17, 2018
    Publication date: July 15, 2021
    Applicants: Massachusetts Institute of Technology, Trustees of Boston University
    Inventors: Caleb J. Bashor, Jason Hung-Ying Yang, Arnaud Gutierrez, Wooseok Steven Ahn, James J. Collins, Brandon Gei-Chin Wong, Ahmad S. Khalil
  • Publication number: 20210071240
    Abstract: The present disclosure relates to compositions and methods for detection of single-stranded breaks (SSBs) in dsDNA, including in genomic DNA. Measurement of the precise location of SSB damage in DNA, e.g.
    Type: Application
    Filed: April 18, 2019
    Publication date: March 11, 2021
    Applicants: MASSACHUSETTS INSTITUTE OF TECHNOLOGY, THE BROAD INSTITUTE, INC.
    Inventors: Sarah DiIorio, Joshua Elacqua, Arnaud Gutierrez, Navpreet Ranu, Paul Blainey
  • Patent number: 10842874
    Abstract: Provided herein are pharmaceutical compositions and kits useful for sensitizing a microorganism or a population of microorganisms to a quinolone antibiotic. In a particular aspect, a carbon source and an electron acceptor can sensitize an antibiotic persistent microorganism to treatment with a fluoroquinolone antibiotic. Methods for sensitizing a microorganism to a quinolone antibiotic, reducing the density-dependent persistence (DDP) of an antibiotic resistant microorganism, and reducing the number of persistent cells in a population are also provided. Theses compositions and methods are useful in treating infections resulting from high-density bacterial cultures, such as pneumonia, genitourinary infections, biofilms, prosthetic graft infections, sepsis, and endovascular infections.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: November 24, 2020
    Assignee: Massachusetts Institute of Technology
    Inventors: James J. Collins, Michael Andrew Lobritz, Arnaud Gutierrez
  • Publication number: 20200199568
    Abstract: Disclosed herein are a high-throughput continuous culture system and novel methodologies for the experimental evolution of natural and synthetic microbes using the continuous culture system. The microbial culture is exposed to a stress ramp function which is overlaid on top of a culture fitness function. The amount of stress applied to the culture is increased in response to increased fitness of the microbial culture.
    Type: Application
    Filed: February 17, 2018
    Publication date: June 25, 2020
    Applicants: Massachusetts Institute of Technology, Trustees of Boston University
    Inventors: Caleb J. Bashor, Jason Hung-Ying Yang, Arnaud Gutierrez, Wooseok Steven Ahn, James J. Collins, Brandon Gei-Chin Wong, Ahmad S. Khalil
  • Publication number: 20190201532
    Abstract: Provided herein are pharmaceutical compositions and kits useful for sensitizing a microorganism or a population of microorganisms to a quinolone antibiotic. In a particular aspect, a carbon source and an electron acceptor can sensitize an antibiotic persistent microorganism to treatment with a fluoroquinolone antibiotic. Methods for sensitizing a microorganism to a quinolone antibiotic, reducing the density-dependent persistence (DDP) of an antibiotic resistant microorganism, and reducing the number of persistent cells in a population are also provided. Theses compositions and methods are useful in treating infections resulting from high-density bacterial cultures, such as pneumonia, genitourinary infections, biofilms, prosthetic graft infections, sepsis, and endovascular infections.
    Type: Application
    Filed: October 23, 2018
    Publication date: July 4, 2019
    Inventors: James J. Collins, Michael Andrew Lobritz, Arnaud Gutierrez